Pachydermoperiostosis: study of epidermal growth factor and steroid receptors. 1995

L Bianchi, and C Lubrano, and A M Carrozzo, and S Iraci, and M Tomassoli, and G Spera, and G Nini
Dipartimento di Medicina Interna, Università di Roma Tor Vergata, Italy.

Pachydermoperiostosis is a rare osteo-cutaneous disease characterized by hypertrophy of bones and surrounding soft tissues. The cutaneous manifestations include coarsening of facial features, cutis verticis gyrata, digital clubbing, hyperhidrosis and seborrhoea. The pathogenetic mechanism of the disease is still debated, and proposed aetiological factors include genetic influences, anomalies in fibroblast activity, or alteration in peripheral blood flow. We studied a patient with the incomplete form of pachydermoperiostosis, assessing epidermal growth factor receptor (EGF-R) and sex hormone steroid receptors (SR) in the affected skin, and also evaluating the urinary excretion of EGF. The results showed high levels of nuclear steroid receptors, increased cytosolic oestrogen receptors, and no detectable progesterone and androgen cytosolic receptors. EGF-R was also undetectable, and the urinary excretion of EGF was elevated. These findings suggest that the increased tissue sensitivity to circulating sex-steroids could induce enhanced tissue EGF/transforming growth factor alpha (TGF-alpha) production and utilization. The SR-EGF-R system could therefore be involved in determining hypertrophy of the affected tissues.

UI MeSH Term Description Entries
D008297 Male Males
D010004 Osteoarthropathy, Primary Hypertrophic A condition chiefly characterized by thickening of the skin of the head and distal extremities, deep folds and furrows of the skin of the forehead, cheeks, and scalp, SEBORRHEA; HYPERHIDROSIS; periostosis of the long bones, digital clubbing, and spadelike enlargement of the hands and feet. It is more prevalent in the male, and is usually first evident during adolescence. Inheritance is primarily autosomal recessive, but an autosomal dominant form exists. Pachydermoperiostosis,Acropachy, Hereditary,Clubbing of Digits,Cranioosteoarthropathy,Currarino Idiopathic Osteoarthropathy,Digital Clubbing, Isolated Congenital,Familial Idiopathic Osteoarthropathy Of Childhood,Hypertrophic Osteoarthropathy, Primary, Autosomal Dominant,Hypertrophic Osteoarthropathy, Primary, Autosomal Recessive,Idiopathic Hypertrophic Osteoarthropathy,Pachydermoperiostosis, Autosomal Dominant,Pachydermoperiostosis, Autosomal Recessive,Primary Hypertrophic Osteoarthropathy, Autosomal Dominant,Touraine-Solente-Gole Syndrome,Acropachies, Hereditary,Autosomal Dominant Pachydermoperiostoses,Autosomal Dominant Pachydermoperiostosis,Autosomal Recessive Pachydermoperiostosis,Cranioosteoarthropathies,Hereditary Acropachies,Hereditary Acropachy,Hypertrophic Osteoarthropathy, Idiopathic,Hypertrophic Osteoarthropathy, Primary,Osteoarthropathy, Currarino Idiopathic,Osteoarthropathy, Idiopathic Hypertrophic,Pachydermoperiostoses, Autosomal Dominant,Primary Hypertrophic Osteoarthropathy,Recessive Pachydermoperiostosis, Autosomal,Touraine Solente Gole Syndrome
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011944 Receptors, Androgen Proteins, generally found in the CYTOPLASM, that specifically bind ANDROGENS and mediate their cellular actions. The complex of the androgen and receptor migrates to the CELL NUCLEUS where it induces transcription of specific segments of DNA. Androgen Receptors,5 alpha-Dihydrotestosterone Receptor,Androgen Receptor,Dihydrotestosterone Receptors,Receptor, Testosterone,Receptors, Androgens,Receptors, Dihydrotestosterone,Receptors, Stanolone,Stanolone Receptor,Testosterone Receptor,5 alpha Dihydrotestosterone Receptor,Androgens Receptors,Receptor, 5 alpha-Dihydrotestosterone,Receptor, Androgen,Receptor, Stanolone,Stanolone Receptors,alpha-Dihydrotestosterone Receptor, 5
D011959 Receptors, Estradiol Cytoplasmic proteins that bind estradiol, migrate to the nucleus, and regulate DNA transcription. Estradiol Receptors,Estradiol Receptor,Receptor, Estradiol
D011980 Receptors, Progesterone Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives. Progesterone Receptors,Progestin Receptor,Progestin Receptors,Receptor, Progesterone,Receptors, Progestin,Progesterone Receptor,Receptor, Progestin
D011987 Receptors, Steroid Proteins found usually in the cytoplasm or nucleus that specifically bind steroid hormones and trigger changes influencing the behavior of cells. The steroid receptor-steroid hormone complex regulates the transcription of specific genes. Corticosteroid Receptors,Receptors, Corticosteroid,Steroid Receptors,Corticosteroid Receptor,Receptors, Steroids,Steroid Receptor,Receptor, Corticosteroid,Receptor, Steroid,Steroids Receptors
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

L Bianchi, and C Lubrano, and A M Carrozzo, and S Iraci, and M Tomassoli, and G Spera, and G Nini
November 1989, The Australian and New Zealand journal of surgery,
L Bianchi, and C Lubrano, and A M Carrozzo, and S Iraci, and M Tomassoli, and G Spera, and G Nini
January 1988, Revue neurologique,
L Bianchi, and C Lubrano, and A M Carrozzo, and S Iraci, and M Tomassoli, and G Spera, and G Nini
January 1999, JPEN. Journal of parenteral and enteral nutrition,
L Bianchi, and C Lubrano, and A M Carrozzo, and S Iraci, and M Tomassoli, and G Spera, and G Nini
March 1991, Cancer,
L Bianchi, and C Lubrano, and A M Carrozzo, and S Iraci, and M Tomassoli, and G Spera, and G Nini
November 1991, Journal of surgical oncology,
L Bianchi, and C Lubrano, and A M Carrozzo, and S Iraci, and M Tomassoli, and G Spera, and G Nini
January 1988, Oncology,
L Bianchi, and C Lubrano, and A M Carrozzo, and S Iraci, and M Tomassoli, and G Spera, and G Nini
February 1981, Molecular and cellular biochemistry,
L Bianchi, and C Lubrano, and A M Carrozzo, and S Iraci, and M Tomassoli, and G Spera, and G Nini
November 1989, The European respiratory journal,
L Bianchi, and C Lubrano, and A M Carrozzo, and S Iraci, and M Tomassoli, and G Spera, and G Nini
September 1985, The British journal of surgery,
L Bianchi, and C Lubrano, and A M Carrozzo, and S Iraci, and M Tomassoli, and G Spera, and G Nini
January 1989, Anticancer research,
Copied contents to your clipboard!